ERVW-1 and infection: Previous investigations of the PT class of HIV-1 Env inhibitors have led to derivation of small and proteolytically stable macrocyclic PTs (cPTs) that potently block virus-cell infection and trigger gp120 shedding and consequent irreversible virus inactivation before host cell encounter [14–23, 37–40].